Patent Applications published on May 5, 2022 - page 4

#901 ✅ Patent 12,036,305 granted on 2024-07-16
US20220133619A1
Human necessities

Makeup priming mousse

#902
US20220133620A1
Human necessities

BIOBASED PEARLESCENT WAXES

#903
US20220133621A1
Human necessities

Cosmetic Composition

#904
US20220133622A1
Human necessities

INSTANT EFFECT EYE CREAM

#905 ✅ Patent 11,759,416 granted on 2023-09-19
US20220133623A1
Human necessities

Antipsychotic injectable depot composition

#906
US20220133624A1
Human necessities

METHOD FOR PRODUCING ORAL DISINTEGRATING FILM COMPRISING POORLY SOLUBLE DRUG

#907
US20220133625A1
Human necessities

METHOD FOR ELIMINATING SPECIFIC PATHOGENIC MICROORGANISMS IN THE BODY

#908
US20220133626A1
Human necessities

TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

#909
US20220133627A1
Human necessities

Stable Therapeutic Formulations

#910 ✅ Patent 11,857,674 granted on 2024-01-02
US20220133628A1
Human necessities

Lubricant formulations

#911
US20220133629A1
Human necessities

FORMULATIONS FOR TREATMENT OF DRY EYE DISEASE

#912
US20220133630A1
Human necessities

PREPARATION METHOD OF SUSTAINED-RELEASE MICROPARTICLES

#913
US20220133631A1
Human necessities

PROCESS OF PREPARING ICE-BASED LIPID NANOPARTICLES

#914
US20220133632A1
Human necessities

PLGA MICROPARTICLES, A SUSTAINED RELEASE FORMULATION THEREOF AND A PRODUCTION METHOD THEREOF

#915
US20220133633A1
Human necessities

PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION

#916 ✅ Patent 11,883,537 granted on 2024-01-30
US20220133634A1
Human necessities

Sustained release solid dosage forms for modulating the colonic microbiome

#917 ✅ Patent 11,547,670 granted on 2023-01-10
US20220133635A1
Human necessities

Delayed release methylphenidate compositions

#918 ✅ Patent 12,350,383 granted on 2025-07-08
US20220133636A1
Human necessities

CATIONIC LIPIDS CONTAINING SILICON

#919 ✅ Patent 11,590,085 granted on 2023-02-28
US20220133637A1
Human necessities

Compositions and methods for organ specific delivery of nucleic acids

#920
US20220133638A1
Human necessities

METHOD FOR PRODUCING NANOPARTICLES

#921 ✅ Patent 12,214,086 granted on 2025-02-04
US20220133639A1
Human necessities

Surface functionalized, host-guest polymer nano-assemblies and methods thereof

#922 ✅ Patent 12,161,764 granted on 2024-12-10
US20220133640A1
Human necessities

Composition and methods of treatment

#923
US20220133641A1
Human necessities

TOPICAL FILM-FORMING SPRAY

#924
US20220133642A1
Human necessities

TOPICAL FILM-FORMING SPRAY

#925 ✅ Patent 12,151,030 granted on 2024-11-26
US20220133643A1
Human necessities

Adhesive patch

#926 ✅ Patent 11,896,723 granted on 2024-02-13
US20220133644A1
Human necessities

Microcell systems for delivering benefit agents

#927 ✅ Patent 11,648,215 granted on 2023-05-16
US20220133645A1
Human necessities

Microcell systems for delivering hydrophilic active molecules

#928
US20220133646A1
Human necessities

SOLUBILIZATE WITH CURCUMIN AND AT LEAST ONE CANNABINOID AS A FURTHER ACTIVE SUBSTANCE

#929
US20220133647A1
Human necessities

LIQUID GUAIFENESIN COMPOSITIONS WITH STABLE EXTENDED RELEASE PROFILES

#930
US20220133648A1
Human necessities

TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES

#931
US20220133649A1
Human necessities

AFFINITY MEDICANT CONJUGATE

#932
US20220133650A1
Human necessities

COMBINATION THERAPY FOR TREATMENT OF BRAIN DISORDERS

#933
US20220133651A1
Human necessities

TREATMENT OF PITT-HOPKINS SYNDROME

#934
US20220133652A1
Human necessities

A FORMULATION FOR IMPROVING SEIZURE CONTROL

#935 ✅ Patent 12,364,673 granted on 2025-07-22
US20220133653A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING LYSOSOMAL STORAGE DISORDERS: AMBROXOL AS TREATMENT AGENT FOR MUCOPOLYSACCHARIDOSES III (SANFILIPPO SYNDROME)

#936 ✅ Patent 12,042,472 granted on 2024-07-23
US20220133654A1
Human necessities

Sublingual epinephrine tablets

#937 ✅ Patent 11,571,399 granted on 2023-02-07
US20220133655A1
Human necessities

Bupropion as a modulator of drug activity

#938
US20220133656A1
Human necessities

METHODS OF TREATING TRIGEMINAL NERVE PAIN

#939 ✅ Patent 12,357,596 granted on 2025-07-15
US20220133657A1
Human necessities

COMPOUNDS FOR PREVENTION AND TREATMENT OF OBESITY AND RELATED DISORDERS

#940
US20220133658A1
Human necessities

TOPICAL ANALGESIC COMPOSITIONS AND METHODS OF USE

#941
US20220133659A1
Human necessities

THERAPEUTIC AGENT FOR CORNEAL DISEASES

#942
US20220133660A1
Human necessities

METHODS OF TREATMENT USING SUSTAINED RELEASE SOTALOL FORMULATIONS

#943 ✅ Patent 12,144,789 granted on 2024-11-19
US20220133661A1
Human necessities

Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth

#944
US20220133662A1
Human necessities

ORAL DRUG, ADJUVANT CANCER THERAPY, AND PET THERAPEUTIC DIET

#945 ✅ Patent 12,059,396 granted on 2024-08-13
US20220133663A1
Human necessities

Method of manufacturing mechanoreception stimulation fabric

#946
US20220133664A1
Human necessities

COMPOSITIONS INCLUDING CINNAMIC ACID AND METHODS OF USE THEREOF

#947 ✅ Patent 12,239,619 granted on 2025-03-04
US20220133665A1
Human necessities

Composition for inducing pili formation in bacterium of genus

#948 ✅ Patent 12,053,445 granted on 2024-08-06
US20220133666A1
Human necessities

Methods of treatment of cholestatic diseases

#949
US20220133667A1
Human necessities

Method of Making a Magnesium Salt of an Alpha Keto Acid of Leucine, Isoleucine, and Valine

#950
US20220133668A1
Human necessities

ISOTOPICALLY MODIFIED COMPONENTS AND THERAPEUTIC USES THEREOF

#951
US20220133669A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF

#952
US20220133670A1
Human necessities

NUTRACEUTICAL FORMULATION FOR UNBLOCKING RECEPTORS

#953
US20220133671A1
Human necessities

ANTI-FIBROTIC NEU3 INHIBITOR COMPOUNDS AND METHODS OF USE

#954
US20220133672A1
Human necessities

NOTCH INHIBITORS FOR THE TREATMENT OF VASCULAR MALFORMATIONS

#955 ✅ Patent 11,786,499 granted on 2023-10-17
US20220133673A1
Human necessities

Ketone body esters of S-beta-hydroxybutyrate and/or S-1,3-butanediol for modifying metabolic function

#956
US20220133674A1
Human necessities

ORALLY INGESTED COMPOSITION FOR IMPROVING SLEEP

#957
US20220133675A1
Human necessities

PHORBOL ESTER COMPOSITIONS AND METHODS OF USE FOR TREATING OR REDUCING THE DURATION OF CYTOPENIA

#958
US20220133676A1
Human necessities

CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF

#959 ✅ Patent 12,090,133 granted on 2024-09-17
US20220133677A1
Human necessities

Topical composition

#960 ✅ Patent 11,541,026 granted on 2023-01-03
US20220133678A1
Human necessities

Method for treatment of rosacea

#961
US20220133679A1
Human necessities

EFFLUX INHIBITOR COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME

#962
US20220133680A1
Human necessities

Compositions of Azadirachta Indica and Methods of Treating Cancer

#963
US20220133681A1
Human necessities

METHOD OF TREATMENT

#964
US20220133682A1
Human necessities

SOLUBILIZATE WITH CURCUMIN AND AT LEAST THE CANNABINOID THC AS A FURTHER ACTIVE SUBSTANCE

#965 ✅ Patent 12,138,241 granted on 2024-11-12
US20220133683A1
Human necessities

Compositions for preventing and treating diabetes

#966 ✅ Patent 11,786,503 granted on 2023-10-17
US20220133684A1
Human necessities

Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity

#967
US20220133685A1
Human necessities

FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS

#968 ✅ Patent 11,478,447 granted on 2022-10-25
US20220133686A1
Human necessities

Solid Δ-tetrahydrocannabinol (Δ-THC) compositions

#969
US20220133687A1
Human necessities

METHODS OF TREATING AND PREVENTING NEURODEGENERATIVE DISEASES WITH HGF ACTIVATING COMPOUNDS

#970
US20220133688A1
Human necessities

MACROCYCLIC LACTONE ANTHELMINTICS AGAINST NEMATODES

#971
US20220133689A1
Human necessities

TONGKAT ALI EXTRACT PRODUCTION PROCESSES AND USES THEREOF

#972
US20220133690A1
Human necessities

Pharmaceutical Composition for Treatment of Bone-Related Disease

#973
US20220133691A1
Human necessities

LASOFOXIFENE TREATMENT OF VVA AND OSTEOPOROSIS IN SURVIVORS OF BREAST CANCER AND OTHER MALIGNANCIES

#974
US20220133692A1
Human necessities

SUPRAMOLECULAR PHOTOPROTECTION OF A PHOTOSENSITIZER

#975 ✅ Patent 12,246,004 granted on 2025-03-11
US20220133693A1
Human necessities

Therapeutic treatment of microsatellite unstable cancers

#976
US20220133694A1
Human necessities

PHARMACEUTICAL USE

#977 ✅ Patent 12,246,006 granted on 2025-03-11
US20220133695A1
Human necessities

Single-dose packaged clotrimazole liquid composition

#978
US20220133696A1
Human necessities

Ifetroban Treatment for Systemic Sclerosis

#979
US20220133697A1
Human necessities

INJECTABLE FORMULATIONS

#980
US20220133698A1
Human necessities

a-SYNUCLEIN AGGREGATE BINDING AGENT AND IMAGING METHOD

#981
US20220133699A1
Human necessities

Antibacterial Compositions

#982
US20220133700A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

#983
US20220133701A1
Human necessities

METHODS OF TREATING PAIN

#984
US20220133702A1
Human necessities

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATORS FOR TREATING AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

#985 ✅ Patent 12,036,210 granted on 2024-07-16
US20220133703A1
Human necessities

Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia

#986
US20220133704A1
Human necessities

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FOR THE TREATMENT OF FSHD

#987
US20220133705A1
Human necessities

Composition for increasing skin thickness

#988
US20220133706A1
Human necessities

TARGETING NAD BIOSYNTHESIS IN THE TREATMENT OF CANCER

#989
US20220133707A1
Human necessities

ARIMOCLOMOL FOR TREATING GLUCOCEREBROSIDASE ASSOCIATED DISORDERS

#990
US20220133708A1
Human necessities

INHALABLE SUSTAINED THERAPEUTIC FORMULATIONS

#991
US20220133709A1
Human necessities

PHARMACEUTICAL COMPOSITION

#992 ✅ Patent 11,969,420 granted on 2024-04-30
US20220133710A1
Human necessities

Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders

#993
US20220133711A1
Human necessities

CAMPTOTHECIN DERIVATIVES

#994
US20220133712A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

#995
US20220133713A1
Human necessities

SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE

#996
US20220133714A1
Human necessities

EXTRACELLULAR MATRIX MODULATING AGENT

#997
US20220133715A1
Human necessities

METHODS OF TREATING VENETOCLAX-RESISTANT ACUTE MYELOID LEUKEMIA

#998 ✅ Patent 11,974,997 granted on 2024-05-07
US20220133716A1
Human necessities

RORgamma modulators and uses thereof

#999
US20220133717A1
Human necessities

RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS

#1000
US20220133718A1
Human necessities

PHARMACEUTICAL FORMULATIONS, PROCESSES FOR PREPARATION, AND METHODS OF USE

#1001
US20220133719A1
Human necessities

Composition for Treating the Eye

#1002 ✅ Patent 12,303,507 granted on 2025-05-20
US20220133720A1
Human necessities

Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia

#1003
US20220133721A1
Human necessities

METHOD FOR TREATING CANCER

#1004
US20220133722A1
Human necessities

PHARMACEUTICAL COMPOSITIONS

#1005 ✅ Patent 12,076,321 granted on 2024-09-03
US20220133723A1
Human necessities

(4-((3R,4R)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2R,6S)-6-(p-tolyl)tetrahydro-2H-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate

#1006 ✅ Patent 11,400,092 granted on 2022-08-02
US20220133724A1
Human necessities

Methods of treating myeloproliferative disorders

#1007 ✅ Patent 11,833,149 granted on 2023-12-05
US20220133725A1
Human necessities

Pulse dosing regimen and methods of treatment

#1008 ✅ Patent 12,257,253 granted on 2025-03-25
US20220133726A1
Human necessities

Triamterene or nolatrexed for use in the treatment of phenylketonuria

#1009
US20220133727A1
Human necessities

COMBINATION THERAPIES FOR USE IN TREATING CANCER

#1010
US20220133728A1
Human necessities

METHODS FOR TREATING VITILIGO LESIONS HAVING IMPROVED EFFICACY

#1011
US20220133729A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING BASAL FOREBRAIN DISEASE

#1012 ✅ Patent 11,433,073 granted on 2022-09-06
US20220133730A1
Human necessities

Compositions and methods for the prevention and treatment of hearing loss

#1013 ✅ Patent 12,280,059 granted on 2025-04-22
US20220133731A1
Human necessities

Acyl-CoA synthetase 4 (ACSL4) inhibitory compound

#1014
US20220133732A1
Human necessities

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR CAIX

#1015
US20220133733A1
Human necessities

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR CD38

#1016 ✅ Patent 12,064,421 granted on 2024-08-20
US20220133734A1
Human necessities

Substituted 1H-pyrazolo[4,3-c]pyridines and derivatives as EGFR inhibitors

#1017
US20220133735A1
Human necessities

CRYSTALLINE FORMS OF A DEOXYCYTIDINE KINASE INHIBITOR AND USES THEREOF

#1018 ✅ Patent 11,878,019 granted on 2024-01-23
US20220133736A1
Human necessities

Uses of pyrimidopyrimidinones as SIK inhibitors

#1019
US20220133737A1
Human necessities

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING BRONCHIECTASIS

#1020
US20220133738A1
Human necessities

GENOTYPE AND DOSE-DEPENDENT RESPONSE TO AN ASBTI IN PATIENTS WITH BILE SALT EXPORT PUMP DEFICIENCY

#1021 ✅ Patent 12,303,516 granted on 2025-05-20
US20220133739A1
Human necessities

Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions

#1022
US20220133740A1
Human necessities

VALPROIC ACID COMPOUNDS AND WNT AGONISTS FOR TREATING EAR DISORDERS

#1023
US20220133741A1
Human necessities

AAntihistamines In Combination With A Range Of Substances For Improved Health

#1024
US20220133742A1
Human necessities

METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA

#1025 ✅ Patent 11,890,290 granted on 2024-02-06
US20220133743A1
Human necessities

Topical treatment of wounds with statins and cholesterol for scar reduction

#1026 ✅ Patent 12,329,763 granted on 2025-06-17
US20220133744A1
Human necessities

COMPOSITION OF LANOSTEROL PRODRUG COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#1027
US20220133745A1
Human necessities

COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

#1028 ✅ Patent 11,883,417 granted on 2024-01-30
US20220133746A1
Human necessities

Methods and compositions related to glucocorticoid receptor antagonists and breast cancer

#1029
US20220133747A1
Human necessities

ESTROGEN RECEPTOR INHIBITORS AND USES THEROF

#1030 ✅ Patent 12,370,202 granted on 2025-07-29
US20220133748A1
Human necessities

METHODS AND COMPOSITIONS FOR INHIBITING THE NLRP3 INFLAMMASOME AND/OR LON PROTEASE

#1031
US20220133749A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER

#1032 ✅ Patent 11,975,011 granted on 2024-05-07
US20220133750A1
Human necessities

Matrix mesalamine extended release minitablets and its process thereof

#1033
US20220133751A1
Human necessities

METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS

#1034
US20220133752A1
Human necessities

MINOCYCLINE FOR THE TREATMENT OF PITT-HOPKINS SYNDROME

#1035
US20220133753A1
Human necessities

COMPOSITIONS AND METHODS USEFUL FOR TREATING DISEASES CHARACTERIZED BY INSUFFICIENT PANTOTHENATE KINASE ACTIVITY

#1036
US20220133754A1
Human necessities

METHOD FOR HYDRATING LYOPHILIZED CYCLOPHOSPHAMIDE COMPOSITION AND PRODUCT THEREOF

#1037 ✅ Patent 11,865,127 granted on 2024-01-09
US20220133755A1
Human necessities

Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor

#1038 ✅ Patent 11,980,630 granted on 2024-05-14
US20220133756A1
Human necessities

Flex-nucleoside analogues, novel therapeutics against filoviruses and flaviviruses

#1039 ✅ Patent 11,986,486 granted on 2024-05-21
US20220133757A1
Human necessities

Aqueous compositions of bortezomib

#1040
US20220133758A1
Human necessities

TREATMENT OF INFLAMMATORY BOWEL DISEASES WITH 2'-FUCOSYLLACTOSE COMPOUNDS

#1041
US20220133759A1
Human necessities

SYNTHETIC COMPOSITION

#1042 ✅ Patent 11,744,843 granted on 2023-09-05
US20220133760A1
Human necessities

Identification and treatment of T-cell epitopes of short H2A oncohistones

#1043
US20220133761A1
Human necessities

NEUTROPHIL APOPTOSIS INDUCED BY NANOPARTICLES FOR TREATING INFLAMMATORY DISEASES

#1044 ✅ Patent 11,684,631 granted on 2023-06-27
US20220133762A1
Human necessities

Method of treating cancer with composition of traditional Chinese medicine and its preparation method thereof

#1045
US20220133763A1
Human necessities

COMPOSITION CONTAINING NICOTINAMIDE MONONUCLEOTIDE AND MOGROSIDE, AND APPLICATION THEREOF

#1046
US20220133764A1
Human necessities

FLAVONOIDS AND ANIMAL HEALTH AND PERFORMANCE

#1047 ✅ Patent 11,779,590 granted on 2023-10-10
US20220133765A1
Human necessities

AMP-activated protein kinase activating compounds and uses thereof

#1048
US20220133766A1
Human necessities

MODULATION OF CILIOGENESIS

#1049
US20220133767A1
Human necessities

TARGETING MICRORNAS TO OVERCOME DRUG TOLERANCE AND RESISTANCE

#1050
US20220133768A1
Human necessities

CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP)

#1051
US20220133769A1
Human necessities

Methods for Treatment of Alport Syndrome

#1052
US20220133770A1
Human necessities

METHODS FOR TREATING MACROPHAGE-MEDIATED DISEASES, AND METHODS OF IDENTIFYING AGENTS USEFUL THEREFORE

#1053
US20220133771A1
Human necessities

Compositions and Methods for Treating or Preventing Gut Permeability-Related Disorders

#1054
US20220133772A1
Human necessities

MEDICATION

#1055
US20220133773A1
Human necessities

MEDICAMENT CONTAINING MODIFIED STARCH FOR THE TREATMENT OF ANASTOMOSES

#1056
US20220133774A1
Human necessities

MODULATION OF MICRORNAS AGAINST MYOTONIC DYSTROPHY TYPE 1 AND ANTAGONISTS OF MICRORNAS THEREFOR

#1057
US20220133775A1
Human necessities

P-ETHOXY NUCLEIC ACIDS FOR IGF-1R INHIBITION

#1058
US20220133776A1
Human necessities

COMPOSITION INCLUDING GLUCOSAMINOGLYCAN DERIVATIVE AND CHEMOKINE RECEPTOR ACTIVITY REGULATOR

#1059
US20220133777A1
Human necessities

METHODS OF TREATING UPPER GASTROINTESTINAL DISORDERS IN PPI REFRACTORY GERD

#1060
US20220133778A1
Human necessities

PHARMACEUTICAL FORMULATIONS USEFUL FOR INHIBITING ACID SECRETION AND METHODS FOR MAKING AND USING THEM

#1061
US20220133779A1
Human necessities

HYPOCHLOROUS ACID INTRAVENOUS SOLUTION, PREPARATION, AND METHOD OF USE THEREOF

#1062
US20220133780A1
Human necessities

COMPOSITIONS AND METHODS FOR INTRACELLULAR IRON DISPLACEMENT PROTEINS

#1063
US20220133781A1
Human necessities

INTERNAL TEAT SEALANTS AND THEIR USE IN THE PREVENTION OF BOVINE MASTITIS IN THE DRY COWB

#1064
US20220133782A1
Human necessities

METHODS AND COMPOSITIONS FOR USING CINNAMALDEHYDE AND ZINC FOR WEIGHT MANAGEMENT

#1065
US20220133783A1
Human necessities

ANTIVIRAL COMPOSITION AND USE OF THE SAME

#1066 ✅ Patent 11,638,722 granted on 2023-05-02
US20220133784A1
Human necessities

Medicine for Covid-19 and treatment

#1067 ✅ Patent 11,642,372 granted on 2023-05-09
US20220133785A1
Human necessities

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

#1068
US20220133786A1
Human necessities

THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES

#1069
US20220133787A1
Human necessities

CELL COMPOSITION, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ATOPIC DISEASE COMPRISING SAME

#1070
US20220133788A1
Human necessities

BAFF THERAPY TO PROMOTE ANTI-TUMOR IMMUNITY

#1071
US20220133789A1
Human necessities

GENERATING CIK NKT CELLS FROM CORD BLOOD

#1072
US20220133790A1
Human necessities

MODIFIED IMMUNE CELLS HAVING ENHANCED ANTI-NEOPLASIA ACTIVITY AND IMMUNOSUPPRESSION RESISTANCE

#1073
US20220133791A1
Human necessities

A Combination of compositions for elimination and enhanced engraftment of hematopoietic stem cells in the bone marrow of a subject

#1074
US20220133792A1
Human necessities

SIGNALING PLATFORMS FOR CHIMERIC ANTIGEN RECEPTOR T CELLS

#1075
US20220133793A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCED LYMPHOCYTE-MEDIATED IMMUNOTHERAPY

#1076 ✅ Patent 12,371,469 granted on 2025-07-29
US20220133794A1
Human necessities

THERAPEUTIC ANTIGEN BINDING PROTEINS SPECIFIC FOR CD93 AND METHODS OF USE THEREOF

#1077
US20220133795A1
Human necessities

Expansion of Tumor Infiltrating Lymphocytes From Liquid Tumors and Therapeutic Uses Thereof

#1078
US20220133796A1
Human necessities

FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE

#1079 ✅ Patent 11,617,766 granted on 2023-04-04
US20220133797A1
Human necessities

Notch receptors with hinge domain

#1080 ✅ Patent 11,369,637 granted on 2022-06-28
US20220133798A1
Human necessities

Restimulation of cryopreserved tumor infiltrating lymphocytes

#1081 ✅ Patent 12,274,714 granted on 2025-04-15
US20220133799A1
Human necessities

Early apoptotic cells for use treating sepsis

#1082
US20220133800A1
Human necessities

TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING

#1083
US20220133801A1
Human necessities

ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES WITH MEMBRANE BOUND INTERLEUKIN 15 TO TREAT CANCER

#1084
US20220133802A1
Human necessities

FUSION POLYPEPTIDE FOR IMMUNOTHERAPY

#1085 ✅ Patent 12,121,861 granted on 2024-10-22
US20220133803A1
Human necessities

Method and system for isolation of mesenchymal stem cell exosomes

#1086 ✅ Patent 12,178,833 granted on 2024-12-31
US20220133804A1
Human necessities

Use of mesenchymal stem cells in treating immune-related diseases

#1087
US20220133805A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS

#1088
US20220133806A1
Human necessities

AMNIOTIC FLUID-DERIVED EXTRACELLULAR VESICLES AND USES THEREOF FOR WOUND HEALING

#1089
US20220133807A1
Human necessities

COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS

#1090
US20220133808A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#1091 ✅ Patent 11,504,401 granted on 2022-11-22
US20220133809A1
Human necessities

Method to prepare a therapeutic balm

#1092 ✅ Patent 12,350,296 granted on 2025-07-08
US20220133810A1
Human necessities

LIQUID PROPOLIS EXTRACT, ITS FORMULATION AND USE THEREOF

#1093 ✅ Patent 11,439,670 granted on 2022-09-13
US20220133811A1
Human necessities

EB-AMDK27 strain and use thereof

#1094
US20220133812A1
Human necessities

AKKERMANSIA MUCINIPHILA EB-AMDK19 STRAIN AND USE THEREOF

#1095 ✅ Patent 11,723,934 granted on 2023-08-15
US20220133813A1
Human necessities

Compositions and methods for the induction of CD8+ T-cells

#1096 ✅ Patent 12,318,412 granted on 2025-06-03
US20220133814A1
Human necessities

and for use in the treatment or prevention of diabetes and bowel diseases

#1097
US20220133815A1
Human necessities

MUSCLE-MODIFYING AGENT

#1098
US20220133816A1
Human necessities

FEED ADDITIVE FORMULATION AND METHODS OF MAKING AND USING THE SAME

#1099
US20220133817A1
Human necessities

Recombinant Bacteria And Uses Thereof

#1100
US20220133818A1
Human necessities

METHOD AND COMPOSITION FOR TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS

#1101
US20220133819A1
Human necessities

MULTI-LACTOBACILLUS COMPOSITION AND APPLICATION THEREOF TO VAGINAL HEALTH OF FEMALES

#1102 ✅ Patent 12,133,874 granted on 2024-11-05
US20220133820A1
Human necessities

Application of breast milk-derived in regulating maternal and infant immune function

#1103
US20220133821A1
Human necessities

MONITORING AND MODIFYING THE MICROBIOME IN PATIENTS WITH RECTOVAGINAL FISTULA

#1104
US20220133822A1
Human necessities

NOVEL BACTERIOPHAGE THAT LYSES ACINETOBACTER GENUS BACTERIA HAVING RESISTANCE TO ANTIBIOTICS

#1105
US20220133823A1
Human necessities

A MODIFIED ONCOLYTIC VIRUS, COMPOSITION AND USE THEREOF

#1106
US20220133824A1
Human necessities

ONCOLYTIC VIRUSES TARGETING STAT3

#1107
US20220133825A1
Human necessities

ONCOLYTIC VIRUSES TARGETING STAT3

#1108
US20220133826A1
Human necessities

NOVEL COMPONENT FOR CONTROLLING BIOLOGICAL FUNCTION

#1109
US20220133827A1
Human necessities

HERBAL COMPOSITION FOR PREVENTING OR TREATING BENIGN PROSTATIC HYPERPLASIA DISEASE

#1110 ✅ Patent 11,903,990 granted on 2024-02-20
US20220133828A1
Human necessities

Compositions and methods for treating and removing seborrheic keratoses

#1111 ✅ Patent 11,554,152 granted on 2023-01-17
US20220133829A1
Human necessities

Antiviral compositions and methods of using same

#1112
US20220133830A1
Human necessities

TOPICAL COMPOSITION FOR CONTROL OF DEMODEX

#1113
US20220133831A1
Human necessities

Sarcopoterium Spinosum Extract for Treating Inflammation

#1114
US20220133832A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING TINNITUS COMPRISING VITIS VINIFERA LEAF EXTRACT AS ACTIVE INGREDIENT

#1115
US20220133833A1
Human necessities

USE OF GRAPE AND/OR SOY SUPPLEMENTS AGAINST COVID-19 AND 92 OTHER VIRUSES AND BACTERIA INCLUDING OTHER UNKNOWN VIRUSES AND BACTERIA

#1116
US20220133834A1
Human necessities

Composition For Inhibiting Proliferation of Influenza Virus

#1117
US20220133835A1
Human necessities

ANTIDIABETIC COMPOSITION COMPRISING GINGER EXTRACT OBTAINED FROM MICROWAVE-PROCESSED GINGER AND METHOD OF PREVENTING OR TREATING DIABETIS MELLITUS

#1118
US20220133836A1
Human necessities

PHARMACEUTICAL COMPOSITION MADE FROM HYDROPHOBIC PHYTOCHEMICALS DISPERSED IN SESAME OIL TO ENHANCE BIOACTIVITY

#1119
US20220133837A1
Human necessities

PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES

#1120 ✅ Patent 12,186,362 granted on 2025-01-07
US20220133838A1
Human necessities

Vasopressin formulations for use in treatment of hypotension

#1121
US20220133839A1
Human necessities

PEPTIDE ANALOGUES WITH BRANCHED AMINO ACID PROBE(S)

#1122
US20220133840A1
Human necessities

Use of microcystin in preparation of drug for preventing or treating organ and tissue fibrosis diseases

#1123
US20220133841A1
Human necessities

NEUROLOGICAL DISEASE TREATMENT WITH ZILUCOPLAN

#1124
US20220133842A1
Human necessities

Use of fungal cyclic peptides of the destruxin type as antibacterial agents active against Clostridium perfringens

#1125 ✅ Patent 11,857,597 granted on 2024-01-02
US20220133843A1
Human necessities

Lipo-glycopeptide cleavable derivatives and uses thereof

#1126 ✅ Patent 12,343,373 granted on 2025-07-01
US20220133844A1
Human necessities

GLYCOPEPTIDE ANTIBIOTICS LIQUID FORMULATIONS AND METHODS AND USES THEREOF

#1127 ✅ Patent 11,433,115 granted on 2022-09-06
US20220133845A1
Human necessities

Glycopeptide antibiotics liquid formulations and methods and uses thereof

#1128
US20220133846A1
Human necessities

NOVEL ANTIMICROBIAL COMPOUND AND USES THEREOF

#1129
US20220133847A1
Human necessities

COMPOSITIONS AND METHODS FOR ALLEVIATING PAIN

#1130
US20220133848A1
Human necessities

METHODS AND COMPOSITIONS FOR RESTORING STMN2 LEVELS

#1131
US20220133849A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SMOOTH MUSCLE DYSFUNCTION

#1132
US20220133850A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NEUROCOGNITIVE DISORDERS

#1133
US20220133851A1
Human necessities

IMMUNOPOTENTIATING OR ANTICANCER ACTIVITY-AUGMENTING COMPOSITION COMPRISING MAL-EXPRESSED STEM CELL LIKE MEMORY T CELL AS ACTIVE INGREDIENT

#1134 ✅ Patent 11,723,953 granted on 2023-08-15
US20220133852A1
Human necessities

Reconstituted high density lipoprotein formulation and production method thereof

#1135
US20220133853A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING ULCERS

#1136 ✅ Patent 12,128,087 granted on 2024-10-29
US20220133854A1
Human necessities

Compositions for treating pathological calcification conditions, and methods using same

#1137 ✅ Patent 12,133,882 granted on 2024-11-05
US20220133855A1
Human necessities

Neuregulin based methods for treating heart failure

#1138 ✅ Patent 11,529,394 granted on 2022-12-20
US20220133856A1
Human necessities

Polypeptide conjugates and methods of uses

#1139
US20220133857A1
Human necessities

ORAL FORMULATION AND TREATMENT OF PTH ANALOG

#1140 ✅ Patent 12,251,426 granted on 2025-03-18
US20220133858A1
Human necessities

Pharmacological compositions for the treatment and prevention of coronavirus disease

#1141
US20220133859A1
Human necessities

ORAL DELIVERY OF ENZYMES BY NANOCAPSULES FOR TARGETED METABOLISM OF ALCOHOL OR TOXIC METABOLITES

#1142 ✅ Patent 12,303,556 granted on 2025-05-20
US20220133860A1
Human necessities

Peptides for treatment and prevention of diabetes and associated disorders

#1143
US20220133861A1
Human necessities

HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT EDEMA

#1144 ✅ Patent 12,161,702 granted on 2024-12-10
US20220133862A1
Human necessities

Methods and compositions for CNS delivery of heparan N-sulfatase

#1145
US20220133863A1
Human necessities

TREATMENT OF SANFILIPPO SYNDROME TYPE B

#1146
US20220133864A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING IMMUNE RESPONSES AGAINST IMMUNOGLOBULIN PROTEASES

#1147
US20220133865A1
Human necessities

CRYSTALLIZED OXALATE DECARBOXYLASE AND METHODS OF USE

#1148
US20220133866A1
Human necessities

Method for the Treatment of a Disease Using Pigment Epithelium-Derived Factor (PEDF)

#1149
US20220133867A1
Human necessities

USE OF ELAFIN FOR DISORDERS ASSOCIATED WITH ELASTASE INDEPENDENT INCREASE IN TROPONIN

#1150
US20220133868A1
Human necessities

TUMOR CELL VACCINES

#1151
US20220133869A1
Human necessities

BREAST CANCER TUMOR CELL VACCINES

#1152 ✅ Patent 12,102,670 granted on 2024-10-01
US20220133870A1
Human necessities

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1153 ✅ Patent 11,771,748 granted on 2023-10-03
US20220133871A1
Human necessities

Methods for treating tumor-induced osteomalacia

#1154
US20220133872A1
Human necessities

A MONOPHOSPHORYL LIPID-A LIPOSOME BASED CANCER VACCINE

#1155
US20220133873A1
Human necessities

CANCER THERAPY

#1156 ✅ Patent 12,059,461 granted on 2024-08-13
US20220133874A1
Human necessities

Methods for making polysaccharide-protein conjugates

#1157
US20220133875A1
Human necessities

METHODS FOR PREVENTING DISEASE OR DISORDER CAUSED BY RSV INFECTION

#1158
US20220133876A1
Human necessities

NOVEL RECOMBINANT INFLUENZA VIRUS HAVING IMMUNE AND THERAPEUTIC RESPONSES TO HETEROLOGOUS INFLUENZA A VIRUS, AND GENETIC VECTOR AND THERAPEUTIC VACCINE COMPRISING SAME

#1159 ✅ Patent 12,350,328 granted on 2025-07-08
US20220133877A1
Human necessities

Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses

#1160
US20220133878A1
Human necessities

METHOD FOR THE SAFE INDUCTION OF IMMUNITY AGAINST RSV

#1161 ✅ Patent 12,357,686 granted on 2025-07-15
US20220133879A1
Human necessities

PORCINE EPIDEMIC DIARRHEA (PED) VIRUS VACCINE COMPOSITION AND PREPARATION METHOD THEREOF

#1162 ✅ Patent 11,872,279 granted on 2024-01-16
US20220133880A1
Human necessities

SARS-CoV-2 antigens and uses thereof

#1163 ✅ Patent 12,214,035 granted on 2025-02-04
US20220133881A1
Human necessities

Herpesvirus compositions and related methods

#1164
US20220133882A1
Human necessities

MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME

#1165
US20220133883A1
Human necessities

METHOD FOR ELICITING AN IMMUNE RESPONSE TO AN IMMUNOGEN

#1166
US20220133884A1
Human necessities

COMPOUNDS USEFUL AS ADJUVANTS

#1167 ✅ Patent 12,064,481 granted on 2024-08-20
US20220133885A1
Human necessities

Compositions and methods employing adenosine deaminase-1 (ADA-1) as an adjuvant

#1168
US20220133886A1
Human necessities

METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC BREAST CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

#1169
US20220133887A1
Human necessities

ANTI-CD40 ANTIBODIES AND USES THEREOF

#1170
US20220133888A1
Human necessities

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER

#1171
US20220133889A1
Human necessities

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#1172
US20220133890A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A GLP-1 AGONIST, AN INSULIN AND METHIONINE

#1173
US20220133891A1
Human necessities

HEMOSTATIC MICROSPHERES

#1174
US20220133892A1
Human necessities

Chimeric Compounds and Methods of Managing Neurological Disorders or Conditions

#1175 ✅ Patent 12,214,043 granted on 2025-02-04
US20220133893A1
Human necessities

Therapeutic nanomaterials

#1176
US20220133894A1
Human necessities

BISPHOSPHONATE-LINKED COMPOUNDS

#1177
US20220133895A1
Human necessities

CAMPTOTHECIN-BASED DIMER COMPOUND, ANTICANCER DRUG AND METHOD OF ELIMINATING CANCER STEM CELL

#1178
US20220133896A1
Human necessities

ANTIMICROBIAL SCAFFOLDS

#1179
US20220133897A1
Human necessities

GLYCOCALYX MIMETIC COATINGS

#1180
US20220133898A1
Human necessities

Derivatisation of Insulin with Polysaccharides

#1181 ✅ Patent 11,744,900 granted on 2023-09-05
US20220133899A1
Human necessities

Preparation of maytansinoid antibody conjugates by a one-step process

#1182 ✅ Patent 11,576,980 granted on 2023-02-14
US20220133900A1
Human necessities

Compositions and methods of treating muscle atrophy and myotonic dystrophy

#1183
US20220133901A1
Human necessities

ROR1 ANTIBODY IMMUNOCONJUGATES

#1184
US20220133902A1
Human necessities

Composition Comprising a Combination of Immune Checkpoint Inhibitor and Antibody-Amatoxin Conjugate for Use in Cancer Therapy

#1185
US20220133903A1
Human necessities

METHODS OF USING A BISPECIFIC ANTIGEN-BINDING CONSTRUCT TARGETING HER2 FOR THE TREATMENT OF BILIARY TRACT CANCERS

#1186
US20220133904A1
Human necessities

TRANSGLUTAMINASE CONJUGATION METHOD WITH A GLYCINE BASED LINKER

#1187 ✅ Patent 12,083,186 granted on 2024-09-10
US20220133905A1
Human necessities

Methods for assembling scavenging particles

#1188
US20220133906A1
Human necessities

VECTORS COMPRISING A NUCLEIC ACID ENCODING LYSOSOMAL ENZYMES FUSED TO A LYSOSOMAL TEARGETING SEQUENCE

#1189 ✅ Patent 12,076,418 granted on 2024-09-03
US20220133907A1
Human necessities

Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

#1190
US20220133908A1
Human necessities

CODING RNA ADMINISTERED INTO THE SUPRACHOROIDAL SPACE IN THE TREATMENT OF OPHTHALMIC DISEASES

#1191
US20220133909A1
Human necessities

HIGHLY EFFICIENT TRANSDUCTION AND LATERAL SPREAD IN THE RETINA BY A NOVEL AAV VIRUS ENHANCED BY RATIONAL DESIGN

#1192
US20220133910A1
Human necessities

NEUROPROTECTION OF NEURONAL SOMA AND AXON BY MODULATING ER STRESS/UPR MOLECULES

#1193
US20220133911A1
Human necessities

MYC, CYCLIN T1 AND/OR CDK9 FOR USE IN THE TREATMENT OF DEGENERATIVE HEART AND CNS DISORDERS

#1194
US20220133912A1
Human necessities

Gene Therapy

#1195
US20220133913A1
Human necessities

SINGLE DOMAIN ANTIBODY TARGETING aVB3 INTEGRIN

#1196
US20220133914A1
Human necessities

OPTICALLY HEAT-GENERATING COMPOSITE MATERIAL, NANOCLUSTER, SUBSTANCE DELIVERY CARRIER AND PHARMACEUTICAL COMPOSITION

#1197
US20220133915A1
Human necessities

HIGH YIELD PRODUCTION OF MICROBUBBLES

#1198 ✅ Patent 11,890,356 granted on 2024-02-06
US20220133916A1
Human necessities

HDAC6 inhibitors and imaging agents

#1199
US20220133917A1
Human necessities

Small Molecules for Dual Function Positron Emission Tomography (PET) and Cell Suicide Switches

#1200
US20220133918A1
Human necessities

COXIB-DERIVED CONJUGATE COMPOUNDS AND METHODS OF USE THEREOF